Summary

BioMimetic Therapeutics, Inc. (BioMimetic) is a biotechnology company. It develops and commercializes products for the healing of musculoskeletal injuries and diseases which include orthopedics, sports medicine and spine applications. The Augment products are based upon the recombinant human platelet-derived growth factor (rhPDGF-BB) in combination with tissue specific matrices as its primary technology platform for promotion of tissue healing and regeneration. The company’s range of products and product candidates combine recombinant protein therapeutics with tissue specific scaffolds that stimulate tissue healing and regeneration. BioMimetic is a subsidiary of Wright Medical Group, Inc., and is headquartered in Franklin, US.



BioMimetic seeks to become the leading company in the field of regenerative medicine through the commercialization of this patented technology; and providing new treatment options for the repair of bone, cartilage, tendons and ligaments.

BioMimetic Therapeutics, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 4
BioMimetic Therapeutics, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 5
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 6
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 7
BioMimetic Therapeutics, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 8
BioMimetic Therapeutics, Inc., Medical Equipment, Deal Details 9
BioMimetic Therapeutics Enters Into License Agreement With Luitpold Pharma 9
Equity Offering 10
BioMimetic Therapeutics Files Registration Statement For Public Offering Of Securities For US$150 Million 10
BioMimetic Therapeutics Completes Public Offering Of Common Stock For US$48 Million 11
BioMimetic Therapeutics Completes Rights Offering Of US$17 Million 13
BioMimetic Therapeutics Completes Private Placement Of Common Stock For US$8 Million 14
Asset Transactions 16
BioMimetic Therapeutics Sells Remaining Dental Business To Luitpold Pharma 16
Acquisition 18
Wright Medical Completes Acquisition Of BioMimetic Therapeutics For Up To US$380 Million 18
BioMimetic Therapeutics, Inc. - Key Competitors 21
Key Employees 22
Locations And Subsidiaries 23
Head Office 23
Other Locations and Subsidiaries 23
Recent Developments 24
Product News 24
Aug 08, 2013: Wright Medical Group, Inc. Announces Receipt of FDA Not Approvable Letter for Augment Bone Graft 24
Jan 03, 2013: BioMimetic Initiates Enrollment In Augment Chronic Tendinopathy Clinical Trial 24
Clinical Trials 25
Jan 03, 2013: BioMimetic Initiates Enrollment In Augment Chronic Tendinopathy Clinical Trial 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables

BioMimetic Therapeutics, Inc., Medical Equipment, Key Facts 1
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 1
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 1
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 1
BioMimetic Therapeutics, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 1
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 4
BioMimetic Therapeutics, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 5
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 6
BioMimetic Therapeutics, Inc., Deals By Market, 2008 to YTD 2014 7
BioMimetic Therapeutics, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 8
BioMimetic Therapeutics Enters Into License Agreement With Luitpold Pharma 9
BioMimetic Therapeutics Files Registration Statement For Public Offering Of Securities For US$150 Million 10
BioMimetic Therapeutics Completes Public Offering Of Common Stock For US$48 Million 11
BioMimetic Therapeutics Completes Rights Offering Of US$17 Million 13
BioMimetic Therapeutics Completes Private Placement Of Common Stock For US$8 Million 14
BioMimetic Therapeutics Sells Remaining Dental Business To Luitpold Pharma 16
Wright Medical Completes Acquisition Of BioMimetic Therapeutics For Up To US$380 Million 18
BioMimetic Therapeutics, Inc., Key Competitors 21
BioMimetic Therapeutics, Inc., Key Employees 22
BioMimetic Therapeutics, Inc., Subsidiaries 23

List of Figures

BioMimetic Therapeutics, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 1
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 4
BioMimetic Therapeutics, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 5
BioMimetic Therapeutics, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 6
BioMimetic Therapeutics, Inc., Medical Equipment, Deals by Market, 2008 to YTD 2014 7

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Inflammation - Pipeline Review, H1 2014

Inflammation - Pipeline Review, H1 2014

  • $ 2 500
  • Company report
  • June 2014
  • by Global Markets Direct

Inflammation - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Inflammation - Pipeline Review, H1 2014', provides an overview of the Inflammation's therapeutic pipeline. This report provides ...

Corcept Therapeutics Incorporated - Product Pipeline Review - 2014

Corcept Therapeutics Incorporated - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • April 2014
  • by Global Markets Direct

Corcept Therapeutics Incorporated - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Corcept Therapeutics Incorporated - Product Pipeline Review - 2014', provides an overview of the Corcept ...

Pharmaceutical in United States: ImmunoCellular Therapeutics, Ltd. – Product Pipeline Review – H2 2011

Pharmaceutical in United States: ImmunoCellular Therapeutics, Ltd. – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

- Product Pipeline Review - H2 2011” provides a detailed overview on the ImmunoCellular Therapeutics, Ltd.’s research and development focus. The report includes information on current developmental ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.